Depression and quality of life issues in patients with amyotrophic lateral sclerosis

Current Treatment Options in Neurology

Volumn 8, Issue 5, 2006, Pages 410-414

  Stromberg, Shannon F ^a   Weiss, David B ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CANNABIS; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANOREXIA; ARTIFICIAL VENTILATION; ATTITUDE TO ILLNESS; CAREGIVER SUPPORT; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; COPING BEHAVIOR; DEATH; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOCTOR NURSE RELATION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEEDING APPARATUS; FRONTOTEMPORAL DEMENTIA; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; LIFESTYLE; MUSCLE WEAKNESS; NEPHROLITHIASIS; NUTRITIONAL STATUS; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHTER; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PHYSICAL DISABILITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RELIGION; RESPIRATORY FAILURE; REVIEW; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 33748441160     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0030-x     Document Type: Review

References (37)

1. Isselbacher KJ, Braunwald E, Wilson JD, et al.: Harrison's Principles of Internal Medicine, edn 13. New York: McGraw-Hill Inc.; 1994.
2. Donaghy M: Brain's Diseases of the Nervous System, edn 11. New York: Oxford University Press; 2001.
3. Walling AD: Amyotrophic lateral sclerosis: Lou Gehrig's disease. Am Fam Physician 1999, 59:1489-1496.
4. Belsh JM., Schiffman PL: Amyotrophic Lateral Sclerosis: Diagnosis and Management for the Clinician. Armonk, NY: Futura Publishing Company; 1996:41-43.
5. Rabkin JG, Wagner GJ, Bene MD: Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000, 62:271-279.
6. Kilani M, Micallef J, Soubrouillard C, et al.: A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:46-54.
7. Bungener C, Piquard A, Pradat P, et al.: Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6:221-225.
8. Moore MJ, Moore PB, Shaw P: Mood disturbances in motor neuron disease. J Neurol Sci 1998, 160(Suppl 1):S53-S56.
9. Hogg KE, Goldstein L, Leigh P: The psychological impact of motor neuron disease Psychol Med 1994, 24:625-632.
10. Tedman BM, Young CA, Williams IR: Assessment of depression in patients with motor neuron disease and other neurologically disabling illnesses. J Neurol Sci 1997, S75-S79.
11. Rabkin JG, Albert SM, Del Bene ML, et al.: Prevalence of depressive disorders and change over time in late stage ALS. Neurology 2005, 65:62-67.
12. Kubler A, Winter S, Ludolph AC, et al.: Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005, 19:182-193.
13. Norquist JM, Jenkinson C, Fitzpatrick R, et al.: Factors which predict physical and mental health status in patients with amyotrophic lateral sclerosis over time. Amyotroph Lateral Scler Other Motor Neuron Disord 2003, 4:112-117.
14. Hillemacher T, Grassel E, Tigges S, et al.: Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:245-249.
15. Simmons Z: Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. Neurologist 2005, 11:257-270.
16. Szcudlik A, Slowik A, Tomik B: The effect of amitriptyline on pathological crying and other pseudobulbar signs. Neurol Neurochir Pol 1995, 29:663-674.
17. de Oliveira-Souza F, de Figueiredo WM, Andreiuolo PA: Pathological crying and unilateral Pontine infarction. Arq Neuropsiquiatr 1995, 53:680-689.
18. Wilson CM, Grace GM, Munoz DG, et al.: Cognitive impairment in sporadic ALS: a pathological continuum underlying a multisystem disorder. Neurology 2001, 57:651-657.
19. Portet F, Cadilbac C, Touchon J, et al.: Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:23-29.
20. Lomen-Hoerth C, Anderson T, Miller B: The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002, 59:1077-1079.
21. Lomen-Hoerth C, Murphy J, Langmore S, et al.: Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003, 60:1094-1097.
22. McCullagh S, Moore M, Gawel M, et al.: Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 1999, 169:43-48.
23. Cudkowicz; ME, Shefner JM, Schoenfeld DA, et al.: A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 2003, 61:456-464.
24. Amtmann D, Weydt P, Johnson KL, et al.: Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 2004, 21:95-104.
25. Clarke S, Hickey A, O'Boyle C, et al.: Assessing individual quality of life in amyotrophic lateral sclerosis. Qual Life Res 2001, 10:149-158.
26. Bromberg MB, Forshew DA: Comparison of instruments addressing quality of life in patients with ALS and their caregivers. Neurology 2002, 58:320-322.
27. Nelson ND, Trail M, Van JN, et al.: Quality of life in patients with amyotrophic lateral sclerosis: perceptions, coping resources, and illness characteristics. J Palliat Med 2003, 6:417-424.
28. Chio A, Gauthier A, Montuschi A, et al.: A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry 2004, 75:1597-1601.
29. Lou JS, Reeves A, Benice T, et al.: Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003, 60:122-123.
30. Plahuta JM, McCulloch BJ, Kasarskis EJ, et al.: Amyotrophic lateral sclerosis and hopelessness: psychosocial factors. Soc Sci Med 2002, 5:2131-2140.
31. Hecht M, Hillemacher T, Grasel E, et al.: Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2002, 3:225-231.
32. Trail M, Nelson ND, Van JN, et al.: Major stressors facing patients with amyotrophic lateral sclerosis: a survey to identify their concerns and to compare with those of their caregivers. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5:40-45.
33. Trail M, Nelson ND, Van JN, et al.: A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003, 209:79-85.
34. Adelman EE, Albert SM, Rabkin JG, et al.: Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology 2004, 62:1766-1770.
35. Miller RG, Anderson FA Jr, Bradley WG, et al.: The ALS patient care database: goals, design, and early results. ALS CARE Study Group. Neurology 2000, 54:53-57.
36. Paz-Rodriguez F, Andrade-Palos P, Llanos-Del Pilar AM: Emotional consequences of providing care to amyotrophic lateral sclerosis patients. Rev Neurol 2005, 40:459-464.
37. Martin J, Turnbull J: Lasting impact in families after death from ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2:181-187.